Lauer, M.S.

health troponin patient disease creatinine clearance genomic creatinine clearance information troponin t level study level pg tests testing value troponin t levels intervention research troponin t infarction genetic creatinine clearance rate percent medicine prevention evidence outcome cancer group utility troponin t status genet death population variant association milliliter model quartile <0.001 2009. result assessment 0.1 ng recommendation health bene fits trial effect genome health outcomes odds ratio change genomic applications risk assessment ratio syndrome fication individual behavior creatinine clearance rates service copyright 2002 massachusetts 30 days treatment egapp khoury point evaluation impact diabetes reclassi fication number university bene fits disease control center interval science validity confidence